
Dual addictions, parallel treatments: nicotine replacement therapy for patients receiving methadone treatment in the Islamic Republic of Iran / Heydari, G.;Talischi, F.;Batmanghelidj, E.;Pajooh, MR.;Boroomand, A.;Zamani, M.;Salehi, A.;Maddah, S.
Tác giả : Heydari, G.;Talischi, F.;Batmanghelidj, E.;Pajooh, MR.;Boroomand, A.;Zamani, M.;Salehi, A.;Maddah, S.
Năm xuất bản : 2013
Thông tin chi tiết
Tóm tắt : | 1-10 This parallel, randomized, open-ended clinical trial tested the impact of nicotine replacement pharmacotherapy during the course of methadone treatment among opiate abusers. A total of 424 men entered the study at 4 drug treatment centres in Tehran, Islamic Republic of Iran. The intervention group received a 6-week regimen of nicotine replacement pharmacotherapy at no charge. After 6 months, 211 persons [99.5%] in the control group continued to smoke and 1 person [0.5%] had quit. In the intervention group, 117 [55.1%] persons smoked, 15 [7.1%] persons had quit and 80 [37.7%] had reduced by more than 50% the number of cigarettes they smoked at the start of the study [P < 0.0001]. The findings suggest that the use of nicotine replacement pharmacology in tandem with methadone maintenance treatment can lead to dramatically improved efficacy for treatment of dual addictions |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/118597 |